- Home
- SBET vs PRAX Comparison
SBET vs PRAX Comparison
Compare SBET & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- PRAX
- Stock Information
- Founded
- SBET 1995
- PRAX 2015
- Country
- SBET United States
- PRAX United States
- Employees
- SBET N/A
- PRAX N/A
- Industry
- SBET Computer Software: Prepackaged Software
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- SBET Technology
- PRAX Health Care
- Exchange
- SBET Nasdaq
- PRAX Nasdaq
- Market Cap
- SBET 618.0M
- PRAX 599.7M
- IPO Year
- SBET 1997
- PRAX 2020
- Fundamental
- Price
- SBET $16.24
- PRAX $51.18
- Analyst Decision
- SBET
- PRAX Strong Buy
- Analyst Count
- SBET 0
- PRAX 10
- Target Price
- SBET N/A
- PRAX $101.00
- AVG Volume (30 Days)
- SBET 21.7M
- PRAX 279.6K
- Earning Date
- SBET 08-14-2025
- PRAX 08-12-2025
- Dividend Yield
- SBET N/A
- PRAX N/A
- EPS Growth
- SBET N/A
- PRAX N/A
- EPS
- SBET N/A
- PRAX N/A
- Revenue
- SBET $3,428,134.00
- PRAX $8,122,000.00
- Revenue This Year
- SBET N/A
- PRAX N/A
- Revenue Next Year
- SBET N/A
- PRAX $6,358.50
- P/E Ratio
- SBET N/A
- PRAX N/A
- Revenue Growth
- SBET N/A
- PRAX 270.02
- 52 Week Low
- SBET $2.26
- PRAX $26.70
- 52 Week High
- SBET $124.12
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- SBET 50.51
- PRAX 69.52
- Support Level
- SBET $9.18
- PRAX $45.70
- Resistance Level
- SBET $12.03
- PRAX $48.00
- Average True Range (ATR)
- SBET 1.85
- PRAX 2.23
- MACD
- SBET 0.32
- PRAX 0.35
- Stochastic Oscillator
- SBET 81.48
- PRAX 95.91
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.